despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
-
.
-
.logout
1243 Used Today
884 Used Today
318 Used Today
254 Used Today
80 Used Today
77 Used Today
110 Used Today
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .